Ultimate access to all questions.
Explanation:
Periodic evaluations of the AI Risk Management Framework evaluations lead to improved processes in governing and managing AI risks. For HealthTech AI, this means a deeper understanding of how their AI systems impact patient care and outcomes, ensuring that these systems are used responsibly and ethically in healthcare settings.
A is incorrect as, while enhanced collaboration and communication are important, they are not the primary focus of periodic AI RMF evaluations. The main goal of these evaluations is to improve risk management processes, not necessarily to directly improve team collaboration.
B is incorrect because increased investment in AI research and development, while beneficial, is not a direct outcome of evaluating the AI RMF. The primary purpose of these evaluations is to enhance risk management practices, not to directly boost R&D funding.
D is incorrect as immediate regulatory approval for new AI systems is not guaranteed by simply evaluating the AI Risk Management Framework. While a proactive approach to risk management can positively influence regulatory perceptions, approval processes involve several other factors and assessments.
Things to Remember
Q.5604 At HealthTech AI, a company specializing in AI for healthcare analytics, there has been an initiative to periodically evaluate the effectiveness of its AI Risk Management Framework. This initiative aims to ensure that the AI systems used for patient data analysis are ethically sound and manage risks effectively. As the head of the risk management team, you are focusing on how these evaluations can improve your AI systems and practices. What benefit can HealthTech AI expect to gain from periodically evaluating the effectiveness of its AI Risk Management Framework?
A
Enhanced collaboration and communication between the AI development and healthcare practitioner teams for better-aligned AI solutions.
B
Increased investment in AI research and development, leading to groundbreaking advancements in AI technologies for healthcare.
C
Improved processes for governing and managing AI risk, including better awareness of how AI decisions affect patient care and outcomes.
D
Immediate regulatory approval for all new AI systems developed, based on the company's proactive approach to risk management.
No comments yet.